• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ACELL, INC. GENTRIX SURGICAL MATRIX PLUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ACELL, INC. GENTRIX SURGICAL MATRIX PLUS Back to Search Results
Model Number MSPL1015
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Wound Dehiscence (1154); Obstruction/Occlusion (2422)
Date of Event 01/25/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This mdr is being submitted due to the reported fascial dehiscence with bowel obstruction requiring emergent surgery and hospitalization.Upon exploration for management of the event, it was the operating surgeon's opinion that the fascial dehiscence was not the result of acell device failure; that the device performed as expected, that the fascial dehiscence was, in fact, the primary event and that the event resulted from patient factors and inherent patient comorbidities.The acell device was explanted and discarded by the hospital, it is not available for evaluation.A review of the manufacturing records for this lot identified no deviations in the production process.The device was manufactured and distributed sterile in compliance with fda, state, local laws and regulations, and acell's operating procedures.Acell conducted suture retention testing on the same retained lot which met specification.
 
Event or Problem Description
On (b)(6) 2019, acell, inc.Was notified by a surgeon that a patient had a fascial dehiscence with bowel obstruction requiring emergent surgery and hospitalization on (b)(6) 2019.The surgeon observed that the primary sutures used to close the defect had ruptured along with the implanted acell device which had been placed as an underlay.The surgeon informed acell that the patient had been non-complaint with post-operative activity instructions.The surgeon explanted and discarded the acell device.The subsequent repair was completed with a non-acell device, a synthetic mesh.There was no infection present after acell implantation or at acell explantation.The patient developed an infection after implantation of the synthetic mesh.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GENTRIX SURGICAL MATRIX PLUS
Common Device Name
GENTRIX SURGICAL MATRIX PLUS
Manufacturer (Section D)
ACELL, INC.
6640 eli whitney dr.
columbia MD 21046
MDR Report Key8405977
Report Number3005920706-2019-00003
Device Sequence Number1811097
Product Code FTM
UDI-Device Identifier00386190001240
UDI-Public(01)00386190001240(17)201031(10)014449
Combination Product (Y/N)N
Initial Reporter StateVA
Initial Reporter CountryUS
PMA/510(K) Number
K162559
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2019
Reporter Type Manufacturer
Report Source distributor,health profession
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date10/31/2020
Device Model NumberMSPL1015
Device Catalogue NumberMSPL1015
Device Lot Number014449
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/15/2019
Initial Report FDA Received Date03/08/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age55 YR
Patient Weight163
-
-